Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11277)
All Articles published online
|
Publishing Process of This Article
|
Mar 10, 2016 (publication date) through Jun 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shipman KE, Strange RC, Ramachandran S. Use of fibrates in the metabolic syndrome: A review. World J Diabetes 2016; 7(5): 74-88 [PMID: 26981181 DOI: 10.4239/wjd.v7.i5.74] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v7/i5/74.htm |
| Number | Citing Articles |
| 1 |
Lu Han, Wen-Jun Shen, Stefanie Bittner, Fredric B Kraemer, Salman Azhar. PPARs: Regulators of Metabolism and As Therapeutic Targets in Cardiovascular disease. Part I: PPAR-α. Future Cardiology 2017; 13(3): 259 doi: 10.2217/fca-2016-0059
|
| 2 |
Christopher Nicholas Floyd. Time to review fibrate prescribing?. Drug and Therapeutics Bulletin 2019; 57(10): 154 doi: 10.1136/dtb.2018.000060
|
| 3 |
Shun Ishibashi, Hidenori Arai, Koutaro Yokote, Eiichi Araki, Hideki Suganami, Shizuya Yamashita. Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial. Journal of Clinical Lipidology 2018; 12(1): 173 doi: 10.1016/j.jacl.2017.10.006
|
| 4 |
Amirhossein Sahebkar, Luis E. Simental-Mendía, Matteo Pirro, Fabrizio Montecucco, Federico Carbone, Maciej Banach, George E. Barreto, Alexandra E. Butler. Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials. Annals of Medicine 2018; 50(6): 485 doi: 10.1080/07853890.2018.1495338
|
| 5 |
Tian Tian Li, Tian Bi Tan, Hai Qing Hou, Xiao Yun Zhao. Changes in peroxisome proliferator-activated receptor alpha target gene expression in peripheral blood mononuclear cells associated with non-alcoholic fatty liver disease. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0901-7
|
| 6 |
Yuliya Tishova, Svetlana Kalinchenko, George Mskhalaya, Geoffrey Hackett, Mark Livingston, Carola König, Richard Strange, Michael Zitzmann, Amar Mann, Amro Maarouf, Sudarshan Ramachandran. Testosterone therapy reduces insulin resistance in men with adult‐onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open‐label phase. Diabetes, Obesity and Metabolism 2024; 26(6): 2147 doi: 10.1111/dom.15520
|
| 7 |
Samuel K. Handelman, Yindra M. Puentes, Annapurna Kuppa, Yanhua Chen, Xiaomeng Du, Mary F. Feitosa, Nicholette D. Palmer, Elizabeth K. Speliotes. Population‐based meta‐analysis and gene‐set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids. Hepatology Communications 2022; 6(11): 3120 doi: 10.1002/hep4.2066
|
| 8 |
Marat V. Ezhov, Gregory P. Arutyunov. Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome. Diseases 2023; 11(4): 140 doi: 10.3390/diseases11040140
|
| 9 |
Herman E. Popeijus. Encyclopedia of Signaling Molecules. 2016; : 1 doi: 10.1007/978-1-4614-6438-9_101552-1
|
| 10 |
Geoffrey Hackett, Nigel Cole, Akhilesh Mulay, Richard C. Strange, Sudarshan Ramachandran. Long‐term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors. BJU International 2019; 123(3): 519 doi: 10.1111/bju.14536
|
| 11 |
Xian-Yu Wei, Yong-Jie Yang, Xiang-Hua Zhu. The effect of bezafibrate in preventing glucolipid abnormalities induced by the antipsychotic risperidone. Psychiatry Research 2019; 281: 112584 doi: 10.1016/j.psychres.2019.112584
|
| 12 |
Shahil H. Patel, Alba Timón-Gómez, Hari Pradhyumnan, Berk Mankaliye, Kunjan R. Dave, Miguel A. Perez-Pinzon, Ami P. Raval. The Impact of Nicotine along with Oral Contraceptive Exposure on Brain Fatty Acid Metabolism in Female Rats. International Journal of Molecular Sciences 2022; 23(24): 16075 doi: 10.3390/ijms232416075
|
| 13 |
María Sánchez-Aguilar, Luz Ibarra-Lara, Agustina Cano-Martínez, Elizabeth Soria-Castro, Vicente Castrejón-Téllez, Natalia Pavón, Citlalli Osorio-Yáñez, Eulises Díaz-Díaz, María Esther Rubio-Ruíz. PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response. International Journal of Molecular Sciences 2023; 24(6): 5321 doi: 10.3390/ijms24065321
|
| 14 |
Carola S König, Mark Atherton, Marco Cavazzuti, Corinna Gomm, Sudarshan Ramachandran. The association of peak systolic velocity in the carotid artery with coronary heart disease: A study based on portable ultrasound. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine 2021; 235(6): 663 doi: 10.1177/09544119211000482
|
| 15 |
Shotaro Kamata, Isao Ishii. PPARα-Ligand Binding Modes Revealed by X-ray Crystallography. YAKUGAKU ZASSHI 2021; 141(11): 1267 doi: 10.1248/yakushi.21-00138
|
| 16 |
Thu Nhan Nguyen, Jeong-Sook Park. Exploring Fenofibrate Formulations for the Treatment of Lipid Disorders: Past, Present, and Future. CardioMetabolic Syndrome Journal 2022; 2(2): 77 doi: 10.51789/cmsj.2022.2.e13
|
| 17 |
Tzu-Tsen Kuo, Yaw-Bin Huang, Ching-Jung Hsieh. Consumption and market share of cholesterol-lowering drugs in high-risk patients before and after the release of the 2013 ACC/AHA cholesterol guidelines: a retrospective observational study. BMJ Open 2020; 10(11): e036769 doi: 10.1136/bmjopen-2020-036769
|
| 18 |
Funda ATAÇ, Yakut GEVREKÇİ, Çiğdem TAKMA, Fatma AKKAYA, Mustafa Can YILMAZ, Tarik AYYILMAZ, Dilsat YEGENOGLU. Bioinformatical Evaluation of PPARA and PPARG Candidate Genes for Milk Quality Characteristics in Turkish Saanen Goats. Journal of Agricultural Faculty of Gaziosmanpasa University 2022; doi: 10.55507/gopzfd.1131221
|
| 19 |
Abeer Anabtawi, Patrick M. Moriarty, John M. Miles. Pharmacologic Treatment of Dyslipidemia in Diabetes: A Case for Therapies in Addition to Statins. Current Cardiology Reports 2017; 19(7) doi: 10.1007/s11886-017-0872-8
|
| 20 |
Ulrich Julius. History of lipidology and lipoprotein apheresis. Atherosclerosis Supplements 2017; 30: 1 doi: 10.1016/j.atherosclerosissup.2017.05.034
|
| 21 |
Surya Shin Ichi Sutanto, Susan Virginia McLennan, Anthony C. Keech, Stephen Morris Twigg. Shortening of telomere length by metabolic factors in diabetes: protective effects of fenofibrate. Journal of Cell Communication and Signaling 2019; 13(4): 523 doi: 10.1007/s12079-019-00521-x
|
| 22 |
Zdenek Tauber, Marketa Koleckova, Katerina Cizkova. Peroxisome proliferator-activated receptor ɑ (PPARɑ)–cytochrome P450 epoxygenases-soluble epoxide hydrolase axis in ER + PR + HER2− breast cancer. Medical Molecular Morphology 2020; 53(3): 141 doi: 10.1007/s00795-019-00240-7
|
| 23 |
Geoffrey Hackett, Nigel Cole, Akhilesh Mulay, Richard C. Strange, Sudarshan Ramachandran. Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile Function. The World Journal of Men's Health 2020; 38(1): 68 doi: 10.5534/wjmh.180052M
|
| 24 |
Justyna Augustyniak, Jacek Lenart, Paweł Gaj, Monika Kolanowska, Krystian Jazdzewski, Piotr Pawel Stepien, Leonora Buzanska. Bezafibrate Upregulates Mitochondrial Biogenesis and Influence Neural Differentiation of Human-Induced Pluripotent Stem Cells. Molecular Neurobiology 2019; 56(6): 4346 doi: 10.1007/s12035-018-1368-2
|
| 25 |
Akihiro Honda, Shotaro Kamata, Makoto Akahane, Yui Machida, Kie Uchii, Yui Shiiyama, Yuki Habu, Saeka Miyawaki, Chihiro Kaneko, Takuji Oyama, Isao Ishii. Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate. International Journal of Molecular Sciences 2022; 23(9): 4726 doi: 10.3390/ijms23094726
|
| 26 |
Sudarshan Ramachandran, Geoffrey I. Hackett, Richard C. Strange. Sex Hormone Binding Globulin: A Review of its Interactions With Testosterone and Age, and its Impact on Mortality in Men With Type 2 Diabetes. Sexual Medicine Reviews 2019; 7(4): 669 doi: 10.1016/j.sxmr.2019.06.006
|
| 27 |
Panniyammakal Jeemon, Rajeev Gupta, Churchill Onen, Alma Adler, Tom Gaziano, Dorairaj Prabhakaran, Neil Poulter. Disease Control Priorities, Third Edition (Volume 5): Cardiovascular, Respiratory, and Related Disorders. 2017; : 389 doi: 10.1596/978-1-4648-0518-9_ch22
|
| 28 |
Yvonne Oligschlaeger, Ronit Shiri-Sverdlov. NAFLD Preclinical Models: More than a Handful, Less of a Concern?. Biomedicines 2020; 8(2): 28 doi: 10.3390/biomedicines8020028
|
| 29 |
Luis E. Simental-Mendía, Mario Simental-Mendía, Adriana Sánchez-García, Maciej Banach, Stephen L. Atkin, Antonio M. Gotto, Amirhossein Sahebkar. Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacological Research 2018; 132: 232 doi: 10.1016/j.phrs.2017.12.030
|
| 30 |
Rasha A. Alshaikh, Ebtessam A. Essa, Gamal M. El Maghraby. Preparation of stabilized submicron fenofibrate crystals on niacin as a hydrophilic hydrotropic carrier. Pharmaceutical Development and Technology 2020; 25(2): 168 doi: 10.1080/10837450.2019.1682609
|
| 31 |
Jae Man Lee. Transcriptional coordination of hepatic autophagy by nutrient-sensing nuclear receptor PPARα and FXR. Annals of Pediatric Endocrinology & Metabolism 2016; 21(4): 193 doi: 10.6065/apem.2016.21.4.193
|
| 32 |
Richard E Kast, Quentin A Hill, Didier Wion, Håkan Mellstedt, Daniele Focosi, Georg Karpel-Massler, Tim Heiland, Marc-Eric Halatsch. Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin. Tumor Biology 2017; 39(5): 101042831769979 doi: 10.1177/1010428317699797
|
| 33 |
Rizwan Khan, Imrana Naseem.
Antiglycation and antioxidant potential of coumaric acid isomers: a comparative
in-vitro
study
. Journal of Biomolecular Structure and Dynamics 2023; : 1 doi: 10.1080/07391102.2023.2267699
|
| 34 |
Sadeesh K. Ramakrishnan, Lucia Russo, Simona S. Ghanem, Payal R. Patel, Ana Maria Oyarce, Garrett Heinrich, Sonia M. Najjar. Fenofibrate Decreases Insulin Clearance and Insulin Secretion to Maintain Insulin Sensitivity. Journal of Biological Chemistry 2016; 291(46): 23915 doi: 10.1074/jbc.M116.745778
|
| 35 |
Carola S. König, Amar Mann, Rob McFarlane, John Marriott, Malcolm Price, Sudarshan Ramachandran. Age and the Residual Risk of Cardiovascular Disease following Low Density Lipoprotein-Cholesterol Exposure. Biomedicines 2023; 11(12): 3208 doi: 10.3390/biomedicines11123208
|
| 36 |
Sikha Thoduvayil, Jonathan S. Weerakkody, Ramalingam Venkat Kalyana Sundaram, Mackenzie Topper, Manindra Bera, Jeff Coleman, Xia Li, Malaiyalam Mariappan, Sathish Ramakrishnan. Rapid Quantification of First and Second Phase Insulin Secretion Dynamics using an In vitro Platform for Improving Insulin Therapy. Cell Calcium 2023; 113: 102766 doi: 10.1016/j.ceca.2023.102766
|
| 37 |
Ethan Alexander, Elizabeth Cristiano, John M. Miles. Precision Medicine in Diabetes. 2022; : 65 doi: 10.1007/978-3-030-98927-9_3
|
| 38 |
Indra Hering, Elke Eilebrecht, Michael J. Parnham, Marc Weiler, Nazende Günday-Türeli, Akif Emre Türeli, Harshvardhan Modh, Paul W.S. Heng, Walter Böhmer, Christoph Schäfers, Martina Fenske, Matthias G. Wacker. Microparticle formulations alter the toxicity of fenofibrate to the zebrafish Danio rerio embryo. Aquatic Toxicology 2021; 234: 105798 doi: 10.1016/j.aquatox.2021.105798
|
| 39 |
Andras Franko, Martin Irmler, Cornelia Prehn, Silke S. Heinzmann, Philippe Schmitt-Kopplin, Jerzy Adamski, Johannes Beckers, Jürgen-Christoph von Kleist-Retzow, Rudolf Wiesner, Hans-Ulrich Häring, Martin Heni, Andreas L. Birkenfeld, Martin Hrabě de Angelis. Bezafibrate Reduces Elevated Hepatic Fumarate in Insulin-Deficient Mice. Biomedicines 2022; 10(3): 616 doi: 10.3390/biomedicines10030616
|
| 40 |
Amro Maarouf, Nathan Lorde, Mark Livingston, Sudarshan Ramachandran. Laboratory medicine: Closer clinical collaboration will lead to evidence-based reporting of results. Edorium Journal of Biochemistry 2021; 5(1): 1 doi: 10.5348/100007B01AM2021ED
|
| 41 |
Junichiro Sonoda, Mark Z. Chen, Amos Baruch. FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases. Hormone Molecular Biology and Clinical Investigation 2017; 30(2) doi: 10.1515/hmbci-2017-0002
|
| 42 |
Reyhaneh Taebi, Mohammad Reza Mirzaiey, Mehdi Mahmoodi, Alireza Khoshdel, Mohammad Ali Fahmidehkar, Maryam Mohammad-Sadeghipour, Mohammad Reza Hajizadeh. The effect of Curcuma longa extract and its active component (curcumin) on gene expression profiles of lipid metabolism pathway in liver cancer cell line (HepG2). Gene Reports 2020; 18: 100581 doi: 10.1016/j.genrep.2019.100581
|
| 43 |
M. Croyal, Z. Kaabia, L. León, S. Ramin-Mangata, T. Baty, F. Fall, S. Billon-Crossouard, A. Aguesse, T. Hollstein, D.R. Sullivan, E. Nobecourt, G. Lambert, M. Krempf. Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD?. Diabetes & Metabolism 2018; 44(2): 143 doi: 10.1016/j.diabet.2017.04.003
|
| 44 |
Herman E. Popeijus. Encyclopedia of Signaling Molecules. 2018; : 3890 doi: 10.1007/978-3-319-67199-4_101552
|